The Trouble with Spikol  |  Make Major Moves  |  PW Style  |  Cup o'Joel

New approach to schizophrenia? I don’t think so.

Mar 21 2006 | Comments 2

f_ab02brain.gif
At first, the article about schizophrenia in today’s New York Times seems promising. It raises the question: Are we overmedicating people with the disease? Are doctors prescribing too much medication and too quickly?

These are valid questions, especially because schizophrenia remains clinically mysterious.

The party line is that schizophrenia is a severe illness that requires aggressive medical treatment. I agree with that, yet I’m open to the idea that there might be alternative ways to address the illness, particularly as science advances and we better understand its etiology.

But coverage of this particular study, I think, is misleading.

The conclusion that some schizophrenics do better without meds is based on Dr. John Bola’s review of six long-term studies involving 623 people. Two studies said patients did better with the meds. Four suggested patients without did better. But, writes the NYT’s Benedict Carey: “Over all, the findings of the studies were a wash, showing no significant advantage for either group.”

If indeed the findings were a wash, with no statistical significance, why am I reading about it in the New York Times? “A wash” should not prompt a conversation that could lead to seriously ill people giving up their medications.

In addition, the studies only included people taking older antipsychotics like Haldol. The new drugs, like Risperdal, Zyprexa, Seroquel, etc., were not included. This is ridiculous. The newer drugs are now the first line of defense against the illness. It’s misleading to demand a new look at treatment based on outdated treatment modalities. We might as well have a conversation about treating pneumonia with leeches.

From the piece:

“‘My hypothesis is that there is a subgroup of patients who are drug-free responders, probably because they have a mild form the disorder,’ Dr. Bola, who has argued against aggressive drug treatment in the past, said in an interview. ‘I think the implications of this are that we need to be additionally careful about medicating people after their first psychotic episode if there’s reason to think they could’ function without medication.”

I’d argue that, given the problems with diagnosis of illnesses like schizophrenia and bipolar disorder (which can also cause psychosis), people with a “mild form” of schizophrenia might not have schizophrenia at all.

A headline like “Revisiting Schizophrenia: Are Drugs Always Needed?” is kind of sexy in these days of complete (and justified) disgust with the pharmaceutical industry. But I’ve seen too many lives destroyed by this illness, too many people who wind up in jail or on the streets because they refuse to take meds.

Let’s not dump those pills so quickly. At least not based on this article.


liz | 10:19 AM | Uncategorized

--susan Says:

While I find much to admire about the NYTimes news coverage, their “reporting” on all clinical trials leaves much to be desired. They pull this sexy-headline/crap data trick all the time.

Mar 21 2:27 PM

Joe Says:

We should consider the generalization that atypical anti-psychotics work better then older medications. I can’t count the number of times I’ve listened to questionable assertions introduced with “Now, with the new atypical anti-psychotics ….” Please see -

“Modern antipsychotic drugs: a critical overview” (CMAJ, June 21,
2005) http://www.cmaj.ca/cgi/content/full/172/13/1703

“Effectiveness of Antipsychotic Drugs in Patients with Chronic
Schizophrenia” (New England Journal of Medicine, September 22, 2005)
http://content.nejm.org/cgi/content/full/353/12/1209

“Interpreting the Results of the CATIE Study” (Psychiatric Services, January 2006)
http://ps.psychiatryonline.org/cgi/content/full/57/1/139

And we shouldn’t forget that the atypicals are not totally free of side effects. For example, “Eli Lilly to Pay About $700M in Zyprexa Settlement” at http://www.law.com/jsp/article.jsp?id=1118394317672

Sadly, medication is too often treatment in its entirety for persons with schizophrenia. Think of the challenges faced by consumers who struggle to build meaningful lives as full participants in the community when their only resource is medication. The following is from a survey of psychiatrists belonging to the American Psychiatric Association’s Practice Research Network (1). Please note that all patients were receiving medication.

“Of 151 adult patients with schizophrenia being treated by 615
psychiatrists in the PRN, 41 percent received both psychotherapy and
medication; the rest received only medication. Moreover, more than half
were receiving three or more different medications, and 14 percent were
receiving five or more.”

and

“Only 38 percent of the 151 patients had case management, and only 21
percent were receiving cognitive-behavioral therapy. A mere 13 percent
were receiving social skills training, and just 3 percent were receiving
vocational training, despite the fact that 73 percent of the patients
were unemployed.”

Could you build a life predicated on medication alone if you didn’t have a life to go back to?

Mar 22 11:07 AM

Reply:

Name *required

Mail *will not be published, required

Website

SUBMIT